Your browser doesn't support javascript.
loading
PROTECT VIII Kids: BAY 94-9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A.
Santagostino, Elena; Kenet, Gili; Fischer, Kathelijn; Biss, Tina; Ahuja, Sanjay; Steele, MacGregor.
Afiliação
  • Santagostino E; Foundation IRCCS Ca' Granda, Maggiore Hospital Policlinico, A. Bianchi Bonomi, Hemophilia and Thrombosis Center, Milan, Italy.
  • Kenet G; Chaim Sheba Medical Center, Israel National Hemophilia Center, Tel Hashomer, Israel.
  • Fischer K; Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Biss T; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Ahuja S; UH Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Steele M; Cumming School of Medicine, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.
Haemophilia ; 26(3): e55-e65, 2020 May.
Article em En | MEDLINE | ID: mdl-32212300
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Proteínas Recombinantes / Fator VIII / Hemofilia A Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Proteínas Recombinantes / Fator VIII / Hemofilia A Idioma: En Ano de publicação: 2020 Tipo de documento: Article